Source:Clinical Therapeutics
Author(s): Wei Liu, Xin Guan, Zhiheng Yu, Ken Chen, Leslie Benet, Suodi Zhai
We present a case of increased cyclosporine concentration and liver function right after the combinational use of cyclosporine and nystatin, which indicated a drug–drug interaction between them. Both the concentration and liver function were decreased after discontinuation of nystatin and remained normal after taking on cyclosporine again. To our knowledge, this is the first case report of the interactions between nystatin and cyclosporine. Enteric P-glycoprotein could play an important role in the pharmacokinetic profile of cyclosporine, which needs further identification by physicians and pharmacists.
http://ift.tt/2HD0Eh4
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου